Efficacy and safety of the Dermatological Soap with ozonated sunflower oil (AGO), or with sulfur, or with sulfur+AGO and Cream with AGO in patients with Scabies.
Not Applicable
- Conditions
- Scabies
- Registration Number
- RPCEC00000439
- Lead Sponsor
- ational Centre for Scientific Research (CNIC)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Patients with confirmed scabies, of both sexes, 19 years or older, who present itching mainly at night and the presence of skin lesions, who agree to participate in the study after signing their informed consent.
Exclusion Criteria
Patients with:
1. Skin lesions with added infection
2. Known hypersensitivity to the products to be used
3. Other skin lesions already diagnosed
4. Moderate-severe cognitive disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Cure clinical (absence of itching and skin lesions ) or clinical improvement (improvement of itching and skin lesions). Measurement time: 7, 14 and 21 days of treatment.<br>2. Negativization of Dermatoscopy (Positive, Negative). Measurement time: 21 days of treatment.
- Secondary Outcome Measures
Name Time Method 1. EASI Scale (Eczema Area and Severity Index). Measurement time: At baseline and, 7, 14 and 21 days of treatment.<br>2. VAS Scale (Visual analogical scale). Measurement time: At baseline and, 7, 14 and 21 days of treatment.<br>3. Quality of Life Questionnaire (EuroQol). Measurement time: At baseline and, 7, 14 and 21 days of treatment.